ClinicalTrials.govpublic full text
Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
covid19, long covid-19, post-covid-19 syndrome, covid-19, naltrexone, nad, nicotinamide adenine dinucleotide, low dose naltrexone, ldn, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 901345
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.